Abiralieva 250 — Abiraterone Acetate 250 mg (120 Tablets)
Abiralieva 250 mg is an innovative anti-tumor medication designed for the targeted therapy of advanced forms of prostate cancer. Its action is based on the selective inhibition of the CYP17 enzyme, which is essential for the synthesis of androgens (male sex hormones) throughout the body. The uniqueness of the drug lies in its ability to block testosterone production in three sources simultaneously: the testes, the adrenal glands, and directly within the tumor itself, depriving cancer cells of the "fuel" needed for growth.
Manufacturer: Allieva. This drug is a high-quality generic produced in accordance with strict GMP standards. It is a full analogue of the original drug Zytiga, providing the same therapeutic efficacy at a significantly more affordable cost of treatment.
Key Advantages:
- ✅ Total Androgen Control: Suppresses testosterone synthesis where other therapies fail.
- ✅ Survival Improvement: Clinically proven that the use of abiraterone significantly prolongs the lives of patients with metastatic cancer.
- ✅ Synergy with Prednisolone: A special administration schedule minimizes side effects and improves the overall tolerability of the therapy.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 06.05.2026
What Customers Say
No reviews yet
Your review can be the first!